Merint Molecular Imaging Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
as on 27-05-2024
- Paid Up Capital ₹ 2.03 Cr
as on 27-05-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2020)
- Profit 123.93%
(FY 2020)
- Ebitda 44.92%
(FY 2020)
- Net Worth 0.38%
(FY 2020)
- Total Assets 0.41%
(FY 2020)
About Merint Molecular Imaging
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 2.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Fazal Manekia and Sukoon Sethi serve as directors at the Company.
- CIN/LLPIN
U74999MH2006PTC163467
- Company No.
163467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Merint Molecular Imaging?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Fazal Manekia  | Director | 02-Aug-2006 | Current |
| Sukoon Sethi | Director | 10-Sep-2012 | Current |
Financial Performance of Merint Molecular Imaging.
Merint Molecular Imaging Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 123.93% increase in profit. The company's net worth moved up by a moderate rise of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merint Molecular Imaging?
In 2017, Merint Molecular Imaging had a promoter holding of 72.37% and a public holding of 27.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Merint Industrial Infrastructure Private LimitedActive 17 years 6 monthsFazal Manekia and Sukoon Sethi are mutual person
Merint Developers Private LimitedActive 26 years 11 monthsFazal Manekia and Sukoon Sethi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Merint Molecular Imaging?
Unlock and access historical data on people associated with Merint Molecular Imaging, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merint Molecular Imaging, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merint Molecular Imaging's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
